Skip to main content
. 2016 Oct 20;7(50):82554–82566. doi: 10.18632/oncotarget.12783

Figure 7. A proposed anti-fibrosis signaling pathway of BBD.

Figure 7

BBD inhibits upstream signal TLR4 expression, and via MyD88 dependent pathway in LPS-induced HSCs. In addition, BBD-serum can down-regulated the expression of α-SMA and inflammatory cytokines throughTLR4/NF-κB pathway. At the same time, BBD can inhibit HSCs proliferation via TLR4/ERK pathway. The element was obtained from Servier Medical Art (http://www.servier.com/servier-medical-art) and the figure was designed and drew by Lei Liang.